Details

Autor(en) / Beteiligte

• Sanz, Ferran
• Pognan, François
• Steger-Hartmann, Thomas
• Díaz, Carlos
• Cases, Montserrat
• Pastor, Manuel
• Marc, Philippe
• Wichard, Joerg
• Briggs, Katharine
• Watson, David K.
• Kleinöder, Thomas
• Yang, Chihae
• Amberg, Alexander
• Beaumont, Maria
• Brookes, Anthony J.
• Brunak, Søren
• Cronin, Mark T. D.
• Ecker, Gerhard F.
• Escher, Sylvia
• Greene, Nigel
• Guzmán, Antonio
• Hersey, Anne
• Jacques, Pascale
• Lammens, Lieve
• Mestres, Jordi
• Muster, Wolfgang
• Northeved, Helle
• Pinches, Marc
• Saiz, Javier
• Sajot, Nicolas
• Valencia, Alfonso
• van der Lei, Johan
• Vermeulen, Nico P. E.
• Vock, Esther
• Wolber, Gerhard
• Zamora, Ismael

Titel

Legacy data sharing to improve drug safety assessment: the eTOX project

Ist Teil von

• Nature reviews. Drug discovery, 2017-12, Vol.16 (12), p.811-812

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2017

Quelle

MEDLINE

Beschreibungen/Notizen

• The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility. The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility.